Fintel reports that on March 16, 2026, Jefferies downgraded their outlook for Incyte (NasdaqGS:INCY) from Buy to Hold. Analyst Price Forecast Suggests 17.55% Upside As of February 25, 2026, the ...

A month has gone by since the last earnings report for Incyte (INCY). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to ...

Good morning, everyone. I'm Andy Berens, senior biotech analyst at Leerink Partners on day 2 of our Global Healthcare Conference in Miami. We're very happy to have with us Incyte. We have Pablo and ...

The big story with the Amalfi Spider is its redesigned roof. The grand tourer’s sleek shape is thankfully unchanged up until the beltline, meaning that the convertible still looks commanding and ...

The first trailer for Spider-Man: Brand New Day is coming on Wednesday, March 18, star Tom Holland has confirmed. But hungry true believers can already chew on the morsels of that new trailer in the ...

Tom Holland is back in superhero mode in the first look at “Spider-Man: Brand New Day,” in theaters July 31 from Sony Pictures. Holland announced on Instagram the comic book tentpole’s official ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

More stories by Kevin P. Meet the new Spider-Man — only kinda the same as the old Spider-Man. The first trailer for Spider-Man: Brand New Day spun its web across the internet on Mar. 18, revealing how ...

With great Spider-Man video games also comes the great responsibility to rank them in a Top 10 list. That’s right: since the first Spider-Man game in 1982 there have been dozens of Spidey games, ...

Investing.com - Stifel maintained a Buy rating and $120 price target on Incyte Corp. (NASDAQ:INCY) following regulatory developments for its cancer drug retifanlimab. With shares currently trading at ...

Investing.com - Jefferies downgraded Incyte (NASDAQ:INCY) to Hold from Buy on Monday and lowered its price target to $94 from $120. The stock currently trades at $92.54 with a market cap of $18.42 ...